Inxight Drugs

U.S. Department of Health & Human Services Divider Arrow

National Institutes of Health Divider Arrow

NCATS

This repository is under review for potential modification in compliance with Administration directives.

Return Home Inxight Drugs

Home
Browse Drugs
Search
- Structure Search
- Sequence Search
Downloads
About

Show Filters

Hide Filters

Development Status

US Approved Rx

6

All Match

Any Match

Exclude Selected

Exclude Selected

Primary Target

GABA-A receptor; anion channel

6

All Match

Any Match

Exclude Selected

Exclude Selected

Highest Phase

Approved

6

All Match

Any Match

Exclude Selected

Exclude Selected

Approval Year

1912

6

All Match

Any Match

Exclude Selected

Exclude Selected

Condition

Anxiety

6

Cholestasis

6

Epilepsy

6

Febrile seizures

6

Hyperbilirubinemia

6

All Match

Any Match

Exclude Selected

Exclude Selected

Treatment Modality

Preventing

6

Primary

6

All Match

Any Match

Exclude Selected

Exclude Selected

CNS Activity

CNS Active

6

All Match

Any Match

Exclude Selected

Exclude Selected

Originator

Farbenfab Vorm Bayer F

6

All Match

Any Match

Exclude Selected

Exclude Selected

Substance Class

Chemical

6

All Match

Any Match

Exclude Selected

Exclude Selected

Code System

CAS

6

FDA UNII

6

PUBCHEM

6

ECHA (EC/EINECS)

5

EVMPD

5

All Match

Any Match

Exclude Selected

Exclude Selected

ATC Level 1

NERVOUS SYSTEM

2

All Match

Any Match

Exclude Selected

Exclude Selected

ATC Level 2

ANTIEPILEPTICS

2

All Match

Any Match

Exclude Selected

Exclude Selected

ATC Level 3

ANTIEPILEPTICS

2

All Match

Any Match

Exclude Selected

Exclude Selected

ATC Level 4

Barbiturates and derivatives

2

All Match

Any Match

Exclude Selected

Exclude Selected

Substance Form

Salts, Hydrates, Esters, etc.

5

Principal Form

1

All Match

Any Match

Exclude Selected

Exclude Selected

Showing 1 - 6 of 6 results

First page disabled
Previous page disabled
1
Next page disabled
Next page disabled

PHENOBARBITAL SODIUM

SW9M9BB5K3

Export Data
Search for Structure

Status:

US Approved Rx (2022)

First marketed in 1912

Class (Stereo):

CHEMICAL (ACHIRAL)

Targets:

GABA-A receptor; anion channel

Conditions:

Tonic-clonic seizures

Febrile seizures

Hyperbilirubinemia

Status epilepticus

Phenobarbital is a barbiturate derivative used to treat insomnia and anxiety, seizures, hyperbilirubinemia in neonates and cholestasis. Phenobarbital promotes binding to inhibitory gamma-aminobutyric acid subtype receptors, and modulates chloride cur...

rents through receptor channels.

PHENOBARBITAL

YQE403BP4D

Export Data
Search for Structure

Status:

US Approved Rx (2022)

First marketed in 1912

Class (Stereo):

CHEMICAL (ACHIRAL)

Targets:

GABA-A receptor; anion channel

Conditions:

Tonic-clonic seizures

Febrile seizures

Hyperbilirubinemia

Status epilepticus

Phenobarbital is a barbiturate derivative used to treat insomnia and anxiety, seizures, hyperbilirubinemia in neonates and cholestasis. Phenobarbital promotes binding to inhibitory gamma-aminobutyric acid subtype receptors, and modulates chloride cur...

rents through receptor channels.

PHENOBARBITAL DIETHYLAMINE

RB423CG92E

Export Data
Search for Structure

Status:

US Approved Rx (2022)

First marketed in 1912

Class (Stereo):

CHEMICAL (ACHIRAL)

Targets:

GABA-A receptor; anion channel

Conditions:

Tonic-clonic seizures

Febrile seizures

Hyperbilirubinemia

Status epilepticus

Phenobarbital is a barbiturate derivative used to treat insomnia and anxiety, seizures, hyperbilirubinemia in neonates and cholestasis. Phenobarbital promotes binding to inhibitory gamma-aminobutyric acid subtype receptors, and modulates chloride cur...

rents through receptor channels.

PHENOBARBITAL CALCIUM

1J4G3UJJ69

Export Data
Search for Structure

Status:

US Approved Rx (2022)

First marketed in 1912

Class (Stereo):

CHEMICAL (ACHIRAL)

Targets:

GABA-A receptor; anion channel

Conditions:

Tonic-clonic seizures

Febrile seizures

Hyperbilirubinemia

Status epilepticus

Phenobarbital is a barbiturate derivative used to treat insomnia and anxiety, seizures, hyperbilirubinemia in neonates and cholestasis. Phenobarbital promotes binding to inhibitory gamma-aminobutyric acid subtype receptors, and modulates chloride cur...

rents through receptor channels.

BARBEXACLONE

291GX1YB65

Export Data
Search for Structure

Status:

US Approved Rx (2022)

First marketed in 1912

Class (Stereo):

CHEMICAL (ABSOLUTE)

Targets:

GABA-A receptor; anion channel

Conditions:

Tonic-clonic seizures

Febrile seizures

Hyperbilirubinemia

Status epilepticus

Phenobarbital is a barbiturate derivative used to treat insomnia and anxiety, seizures, hyperbilirubinemia in neonates and cholestasis. Phenobarbital promotes binding to inhibitory gamma-aminobutyric acid subtype receptors, and modulates chloride cur...

rents through receptor channels.

MAGNESIUM PHENOBARBITAL

RSK622Z0BN

Export Data
Search for Structure

Status:

US Approved Rx (2022)

First marketed in 1912

Class (Stereo):

CHEMICAL (ACHIRAL)

Targets:

GABA-A receptor; anion channel

Conditions:

Tonic-clonic seizures

Febrile seizures

Hyperbilirubinemia

Status epilepticus

Phenobarbital is a barbiturate derivative used to treat insomnia and anxiety, seizures, hyperbilirubinemia in neonates and cholestasis. Phenobarbital promotes binding to inhibitory gamma-aminobutyric acid subtype receptors, and modulates chloride cur...

rents through receptor channels.

HHS VULNERABILITY DISCLOSURE

For language access assistance, contact the NCATS Public Information Officer

National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966


			version 1.1